Your Article Summary
Use of antipsychotics in neuropsychiatric symptoms of dementia
Geriatrics, 05/18/09
Kalapatapu RK et al. - Antipsychotic medications have a modest effect on the neuropsychiatric symptoms of dementia, but product labels warn of the excess risk of death and morbidity associated with their use in older patients. As such, these agents should not be the first choice for the treatment of behavioral and psychotic symptoms of dementia. Nevertheless, a trial of these agents may be indicated in instances in which the severity of symptoms is extreme, or symptoms do not respond to nonpharmacologic methods or other medications...There is no evidence to suggest differences in effectiveness between atypical and conventional antipsychotics; therefore, the choice of an antipsychotic for neuropsychiatric symptoms often relies on side effect profile and individual patient circumstances. Extrapyramidal symptoms and QTc prolongation are concerns with conventional antipsychotic agents. The incidence of cerebrovascular events with either atypical or conventional antipsychotics appears increased compared with placebo. A discussion of the risk-benefit ratio of antipsychotics with the patient's family and/or caregivers should precede the decision to use these agents.
Related Articles
Prevalence of dementia and major dementia subtypes in Spanish populations: A reanalysis of dementia prevalence surveys, 1990-2008
BMC Neurology, 10/23/09
Relevance Score: 94%
High Prevalence of Orthostatic Hypotension in Mild Dementia
Dementia and Geriatric Cognitive Disorders, 10/15/09
Relevance Score: 93%
Predicting dementia: role of dementia risk indices
Future Neurology, 10/02/09
Relevance Score: 93%
Lipids peroxidation markers in Alzheimer's disease and vascular dementia
Geriatrics and Gerontology International, 11/17/09
Relevance Score: 91%
Promiscuous modulation of ion channels by anti-psychotic and anti-dementia medications
Medical Hypotheses, 10/05/09
Relevance Score: 91%
Today in Dementia...keeping you current
Receive free subspecialty "5-minute updates" via email
Magnetic Resonance Imaging in Lewy Body Dementias
Dementia and Geriatric Cognitive Disorders, 12/09/09
Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD)
Archives of Gerontology and Geriatrics, 12/09/09
Inflammation: A bridge between postoperative cognitive dysfunction and Alzheimer's disease
Medical Hypotheses, 12/09/09
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Central Levodopa Influx and the Clinical Motor Response to Levodopa in Patients With Parkinson Disease Complicated With Motor Fluctuations and Dyskinesias
Clinical Neuropharmacology, 12/09/09
Levodopa-Induced Dyskinesias in Parkinson Disease Are Independent of the Extent of Striatal Dopaminergic Denervation: A Pharmacological and SPECT Study
Clinical Neuropharmacology, 12/09/09
Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD)
Archives of Gerontology and Geriatrics, 12/09/09
Today in Neuropsych Sciences...keeping you current
Receive free subspecialty "5-minute updates" via email
Verbal Working Memory Impairment in Patients With Current Episode of Unipolar Major Depressive Disorder and in Remission
Clinical Neuropharmacology, 12/09/09
Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD)
Archives of Gerontology and Geriatrics, 12/09/09
Psychophysiological disorders among buprenorphine patients
International Journal of Psychiatry in Clinical Practice, 12/09/09

See Latest Articles